statistiche ricercatore

Continente	#
NA - Nord America	1.204
AS - Asia	553
EU - Europa	445
SA - Sud America	63
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	18
Totale	2.301

Nazione	#
US - Stati Uniti d'America	1.164
SG - Singapore	172
GB - Regno Unito	120
CN - Cina	100
BD - Bangladesh	85
IT - Italia	81
FI - Finlandia	55
HK - Hong Kong	55
BR - Brasile	50
VN - Vietnam	48
SE - Svezia	45
DE - Germania	36
FR - Francia	23
CA - Canada	22
RU - Federazione Russa	22
UA - Ucraina	21
IN - India	20
KR - Corea	14
IE - Irlanda	13
TR - Turchia	12
JP - Giappone	9
BG - Bulgaria	8
EG - Egitto	7
MX - Messico	7
ID - Indonesia	6
IL - Israele	5
AR - Argentina	4
CL - Cile	4
IQ - Iraq	4
MY - Malesia	4
PK - Pakistan	4
UZ - Uzbekistan	4
AT - Austria	3
BY - Bielorussia	3
ES - Italia	3
MA - Marocco	3
PL - Polonia	3
RO - Romania	3
SC - Seychelles	3
EC - Ecuador	2
LB - Libano	2
LT - Lituania	2
PA - Panama	2
PR - Porto Rico	2
RS - Serbia	2
SA - Arabia Saudita	2
TH - Thailandia	2
TN - Tunisia	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BZ - Belize	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
DK - Danimarca	1
GE - Georgia	1
GF - Guiana Francese	1
GP - Guadalupe	1
GT - Guatemala	1
HN - Honduras	1
JM - Giamaica	1
KE - Kenya	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
ML - Mali	1
PH - Filippine	1
SV - El Salvador	1
Totale	2.283

Nome	#
Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay.	398
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis	326
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome	307
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia	299
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution	289
IN VITRO TOXICITY OF METAL NANOPARTICLES IN NEURONAL AND GLIAL CELLS	239
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes	224
In-vitro assessment of new methods for cell massive uptake based on nanoparticles transfection	219
Totale	2.301

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	114	0	0	0	0	7	18	3	2	23	17	28	16
2022/2023	160	14	32	9	8	27	22	4	10	26	1	2	5
2023/2024	96	2	5	6	15	31	7	2	11	0	5	2	10
2024/2025	339	10	5	5	24	71	50	15	19	53	16	31	40
2025/2026	820	36	24	40	56	110	62	136	28	66	72	109	81
2026/2027	216	17	40	57	69	33	0	0	0	0	0	0	0
Totale													2.301